Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study-Reference-Cited by-同舟云学术

Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study

Published:2016-05 Issue: Volume:30 Page:77-81
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Perez Botero J.,Ormsby W.D.,Ashrani A.A.,McBane R.D.,Wysokinski W.E.,Patnaik M.M.,Lewis B.R.,Grill D.E.,Pruthi R.K.,Heit J.A.

Publisher

Elsevier BV

Subject

Internal Medicine

Reference27 articles.

1. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V;Dahlback;Proc Natl Acad Sci U S A,1994

2. Resistance to activated protein C as a basis for venous thrombosis;Svensson;N Engl J Med,1994

3. Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia;Sun;Blood,1994

4. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals;Camire;J Biol Chem,1995

5. Characterization of the molecular defect in factor VR506Q;Kalafatis;J Biol Chem,1995

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic factors, risk prediction and AI application of thrombotic diseases;Experimental Hematology & Oncology;2024-08-27

2. Administrative codes inaccurately identify recurrent venous thromboembolism: The CVRN VTE study;Thrombosis Research;2020-05

3. The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis;Blood Coagulation & Fibrinolysis;2020-04

4. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A;Thrombosis Research;2019-10

5. Thrombophilia;Consultative Hemostasis and Thrombosis;2019